Neoleukin Therapeutics Q3 EPS $(2.26) Down From $(0.64) YoY

Neoleukin Therapeutics (NASDAQ:NLTX) reported quarterly losses of $(2.26) per share. This is a 253.12 percent decrease over losses of $(0.64) per share from the same period last year.

Benzinga · 11/13/2019 14:16

Neoleukin Therapeutics (NASDAQ:NLTX) reported quarterly losses of $(2.26) per share. This is a 253.12 percent decrease over losses of $(0.64) per share from the same period last year.